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Abstract: In the normal physiological state, intestinal epithelial cells act as a defensive frontline of host
mucosal immunity to tolerate constant exposure to external stimuli. In this study, we investigated
the potential anti-inflammatory and gut permeability protective effects of Laminaria japonica (LJ)
water extract (LJE) and three types of fermented Laminaria japonica water extracts (LJE-F1, LJE-F2,
and LJE-F3) in lipopolysaccharide (LPS)-stimulated Caco-2, human intestinal epithelial cells. All
four extracts significantly decreased the production of nitric oxide and interleukin-6 induced by LPS
stimulus. In addition, LJE and the three types of LJE-Fs also inhibited LPS-induced loss of monolayer
permeability, as assessed by changes in transepithelial electrical resistance. All four LJ extracts
significantly prevented the inhibition of the protein levels of occludin, whereas LJE, LJE-F1, and LJE-F3
significantly attenuated the reduction in phosphorylation of adenosine monophosphate-activated
protein kinase compared with the LPS-treated group in Caco-2 cells. In conclusion, LJE and
its fermented water extracts appear to have potential gut health-promoting effects by reducing
inflammation and partially regulating the tight junction-related proteins in human intestinal epithelial
cells. Thus, additional studies are warranted to evaluate Laminaria japonica as a therapeutic agent for
inflammatory bowel diseases.
Keywords: Caco-2 cells; Laminaria japonica; fermentation; anti-inflammatory; gut permeability;
inflammatory bowel disease
1. Introduction
The gastrointestinal (GI) tract is constantly challenged by numerous external stimuli, and the
epithelial cells function as a frontline defense barrier from those potential xenobiotics by closely
regulating the tight junction (TJ). Disrupted TJs that lead to increased gut permeability cause barrier
malfunction of epithelial cells—the so-called ‘leaky gut’. In this physiologically vulnerable state,
various pathogens, antigens, and endotoxins can easily penetrate the epithelial lining of the GI tract
and may provoke abnormal intestinal inflammation and the development of chronic inflammatory
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diseases, such as inflammatory bowel disease (IBD) [1]. The increased incidence of IBDs is a major
public health problem, because it affects patients’ quality of life enormously [2]. The treatments
for IBDs are mainly to manage the inflammatory status with different drug categories including
aminosalicylates, corticosteroids, anti-tumor necrosis factor alpha drugs, antibiotics, probiotics, and
immunosuppressants, which sometimes are inadequate [3]. In recent decades, looking for alternative
medicines from natural sources has received much attention to improve the lack of desirable efficacy
and poor tolerability of the current drugs for treating IBDs [4–6].
In particular, intestinal epithelial cells play a critical role as a defensive frontline of host mucosal
immunity to tolerate constant exposure to external stimuli including Gram-negative bacteria [7]. Caco-2,
a human intestinal epithelial cell line, is the most well-established cell line for investigating intestinal
barrier integrity and function [8]. Various stimuli have been used to induce inflammatory status to
mimic a similar physiological condition to that in Caco-2 cells; one of them is a lipopolysaccharide
(LPS), a principal component of the outer membrane of Gram-negative bacteria [9–11]. LPS is known
to trigger an inflammatory signaling cascade via activating Toll-like receptor (TLR)-4, a member of
the transmembrane protein family that functions as a pattern-recognition receptor [12]. Upon LPS
stimuli, epithelial cells produce proinflammatory cytokines to disrupt TJs, leading to increased gut
permeability [10,13].
Various seaweeds are commonly consumed as foods worldwide, especially in countries in Asia.
Laminaria japonica (LJ) is a popular, edible, brown seaweed that is present in high quantities on Jeju
Island, Korea [14]. In general, LJ contains soluble fibers, such as alginate and fucoidan, as well as
fat-soluble components, such as fucoxanthin and fucosterol, along with minerals such as magnesium,
iodine, calcium, iron, and zinc [15,16]. Its biological functions have been extensively investigated
in both in vitro and in vivo models. LJ extracts have been shown to have anti-obesity, antidiabetic,
anti-inflammatory, anti-oxidant, and anticancer effects in a number of studies [15,17–19]. Furthermore,
the application of fermentation to LJ has attracted attention as a tool to enhance its biological functions,
as well as attenuate its potential toxicity [20–23]. Fermentation with microorganism(s) has been shown
to improve the extraction of bioactive substances from original materials [20,23,24]. For example,
Kang et al. [20] reported that the administration of Lactobacillus brevis-fermented LJ (1.5 g/day for
four weeks) enhanced the antioxidant defense system in humans. Fermented LJ extract protected
oxidative-stressed porcine kidney epithelial cells. In addition, Lin et al. [21] demonstrated the enhanced
anti-inflammatory effects of LJ fermented by Bacillus subtilis (200 µg/mL), whereas LJ water extract did
not cause a significant decrease compared with the LPS-stimulated group in consideration of nitric
oxide (NO) production induced by LPS in mouse macrophages, RAW 264.7 cells.
Thus, most previous studies on fermented Laminaria japonica have been limited to its antioxidant
effects and anti-inflammatory effects. In the present study, we utilized Caco-2, a well-studied human
intestinal epithelial cell line, for the investigation of in vivo intestinal epithelial barrier integrity and
function [8], to evaluate the potential protective effect and mechanism(s) of LJ water extract (LJE)
and/or three types of fermented LJEs by probiotic strains on LPS-stimulated TJ destruction in human
intestinal epithelial cells, which may provide a novel approach for the treatment of IBDs.
2. Materials and Methods
2.1. Preparation of Extracts from Laminaria japonica
Raw Laminaria japonica was purchased from a traditional market in Jeju and processed into
powder, as previously described [17]. The detailed sample preparation from LJE and fermented
LJEs is described in Figure 1. Briefly, the freeze-dried LJ powder (3 g) was extracted using 200 mL
double-distilled water in a shaking water bath for 24 h at room temperature, followed by vacuum
filtration. For LJE, the solution was freeze dried and dissolved in Dulbecco’s phosphate-buffered
saline (DPBS, Gibco, Gaithersburg, MD, USA). For the LJE-Fs, the vacuum-filtered solution (100 mL)
was mixed with 6 × 1010 of Lactobacillus rhamnosus LGG (LGG, 3 × 1010/g, CHR-Hansen, Roskilde,
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Denmark) for LJE-F1, Bifidobacterium animalis ssp. lactis BB-12 (BB-12, 3 × 1010/g, CHR-Hansen) for
LJE-F2, or LGG and BB-12 for LJE-F3. Both LGG and BB-12 are well-established probiotic strains [25],
provided by the research and development center of Maeil Dairies Co. (Pyeongtaek, Gyeonggi-do,
Korea). Based on the preliminary experiment results and a published literature search [21,24,26–29],
to optimize the fermentation process, fermentation of LJ was carried out at 37 ◦C for 48 h and then
terminated at ≤ pH 4.0, followed by heat treatment at 120 ◦C for 20 min and freeze drying. The final
powder of three LJE-Fs was dissolved in DPBS and filtered for cell culture experiments.
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Figure 1. A flow diagram of Laminaria j ponica ( ater extract (LJE) and fermented LJ water extract
(LJE-F1, -2, and -3) preparation. Abbreviations: LGG; Lactobacillus rhamnosus LGG, BB-12; Bifidobacterium
animalis ssp. lactis BB-12; DPBS, Dulbecco’s phosphate-buffered saline; and RT, room temperature.
2.2. Measurement of pH, Sugar, and Reducing Sugar Contents
Alterations of LJEs by the fermentation process ere measured in pH, sugar, and reducing sugar
contents of extracts. The ph nol-sulf ric acid od was utilized to check changes in total sugar
contents before and after fermentation of LJE [30]. Briefly, 10-µL samples were mixed with 10 µL of
5% phenol solution, and then, 50 µL 18 M H2SO4 was added. The reaction mixture was set at room
temperature for 30 min, and the absorbance was measured at 490 nm. Based on a D-Gl cose standard
solution (Kat yama Chemica , Osaka, J pan), the total sugar contents wer calculated. Reducing sugar
contents in samples were measured by the dinitrosalicylic acid (DNS) method [31]. Then, 1 mL of
diluted sample was mixed well with 2 mL of DNS (3,5-dinitrosalicylic acid, 2 M NaOH, and potassium
sodium tartrate) and incubated in boiling water for 15 min. Absorbance was measured at 540 nm,
and D-glucose was also used as a standard.
2.3. Total Polyphenol Contents
The Folin-Denis method was used to determine the total polyphenol contents of LJE samples
before and after fermentation [32]. First, 50-mL samples were mixed with 50 µL of 1 M Folin-Ciocalteu’s
phenol reagent (Merck KGaA, Burlington, MA, USA) and incubated at room temperature for 6 min.
The reaction was further processed by adding 100 µL of 2% Na2CO3 and incubating for 30 min.
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Absorbance was measured at 720 nm, and gallic acid (Sigma-Aldrich, St. Louis, MO, USA) was used as
a standard compound.
2.4. Cell Culture
Caco-2 cells were purchased from the Korean Cell Line Bank (Seoul, Korea) and cultured in
Dulbecco’s modified Eagle’s (DMEM-low glucose) supplemented with 10% (v/v) fetal bovine serum
(FBS), 1% (v/v) penicillin/streptomycin, and 1% (v/v) of 100× non-essential amino acid. Caco-2 cells were
refed with fresh medium every two days during cell growth and differentiation under a humidified
atmosphere of 5% CO2 at 37 ◦C. For the experiments, cells were used 16-21 days after reaching
confluence to allow for differentiation into intestinal epithelial cells. Cells were used between passages
10 and 20. All cell culture media and reagents were from Gibco (Gaithersburg, MD, USA).
2.5. Cell Viability Assay
Cell viability was determined by 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay [33]. Briefly, Caco-2 cells were plated in a 24-well plate at a concentration of 1 × 105 cells/well
and stabilized for 24 h. Then, cells were treated with different concentrations of LJE or LJE-Fs (0, 50, 100,
200, or 400 µg/mL) for 24 h. At the end of treatment, the culture media was replaced, and 100 µL of
2 mg/mL MTT reagent was added for another 4 h at 37 ◦C. Then, 100 µL of DMSO (dimethyl sulfoxide)
was added to each well to dissolve the formazan product from cells and the absorbance was measured
at 540 nm using a microplate reader (Molecular Devices, San Jose, CA, USA).
2.6. Nitric Oxide Production Measurement
Alteration of nitric oxide (NO) production by LJE and/or LJE-Fs treatment was measured in
collected cultured Caco-2 media using the Griess Reagent system [34]. Caco-2 cells were seeded at
0.25 × 106 cells/well (24-well plate, Corning, Oneonta, NY, USA). The cell culture medium was changed
every 2 days until the cells were fully differentiated (14–21 days). Next 100 µg/mL of LJE and LJE-Fs
were applied to cells for 6 h. Then, 1 µg/mL of lipopolysaccharide (Sigma-Aldrich) was added, and the
solution incubated for another 24 h [9]. At the end of treatment, 100 µL of cultured medium was
transferred to a 96-well plate, and the same volume of Griess reagent (Sigma-Aldrich) was added.
The reaction was carried out for 10 min at room temperature, and absorbance was measured by a
microplate reader at 540 nm. Relative nitric oxide (NO) production was calculated based on the
LPS-treated group, which was considered to be 100%.
2.7. Transepithelial Electrical Resistance
To determine the effects of LJE and LJE-Fs on the TJ stabilization of Caco-2 cells, transepithelial
electrical resistance (TEER) assay was performed according to a previous study with modifications [35].
Cells were differentiated into polarized monolayers by culture on 12-transwell plates (Corning, Oneonta,
NY, USA) at a seeding density of 0.25 × 106 cells/well. The volume of medium added to the upper and
lower compartment was 0.5 mL and 1.5 mL, respectively. TEER was measured using a Millicell-ERS
resistance system (Millipore, MA, USA) that includes a dual-electrode volt-ohm-meter. TEER was
calculated as TEER Ωcm2 = (target TEER value (T24) − control TEER value)/(target TEER value
(T0) − control TEER value) (Ω) × A (cm2); being, target TEER value, transmembrane resistance; control
TEER value, intrinsic resistance of a cell-free media; and A, the surface area of the membrane in cm2.
Cells were rinsed with DPBS, and then, Hanks’ Balanced Salt Solution (HBSS, Gibco, Gaithersburg,
MD, USA) was added in both compartments. Cells were treated with LJE or LJE-Fs (100 µg/mL), which
was added to the upper compartment for 6 h, and LPS (1 µg/mL) was subsequently added to the
lower compartment for an additional 24 h. The TEER values were measured at 0 h (T0) and the end of
treatment (Tend).
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2.8. Western Blot Analysis and ELISA
Cells in six-well plates at a seeding density of 1 × 106 cells/well were cultured for 14-21 days. Cells
were then pre-incubated for 6 h with 100 µg/mL LJ or LJE-Fs and incubated for 24 h in the absence
or presence of LPS (100 µg/mL). Collected media was used to measure inflammatory cytokines by
ELISA kit (TNF-α and IL-6; BD PharMingen, San Diego, CA, USA) according to the manufacturer’s
protocol. After rinsing with DPBS three times, cells were lysed by adding 100 µL of lysis buffer
(20 mM Tris-HCL (pH 7.4), 5 mM Na4P2O7, 10 mM NaF, 100 mM NonidetP-40, 1% NaVO4, and
0.5% EZ block), and centrifugation was carried out for 15 min at 14,000 rpm and 4 ◦C. Proteins
were quantified using a protein assay kit (Thermo Fisher Scientific, Lombard, IL, USA). Proteins
(50 µg/24 µL) were then separated by 10% SDS-PAGE (SDS polyacrylamide gel electrophoresis) at
80 V for 1.5 h and then 120 V for 0.5 h and transferred to nitrocellulose membranes (Amersham
Co., Freiburg, Germany) at 300 mA for 1.5 h. Membranes were then blocked with 5% blocking
buffer (Bio-rad, Hercules, CA, USA) for 2 h followed by the indicated antibody (phospho-AMPK
(adenosine monophosphate (AMP)-activated protein kinase)α (Thr 172), AMPKα, GAPDH (1:1000,
Cell signaling technology, MA, USA), occludin (65 kDa, 1:200, Santa Cruz, CA, USA)) at 4 ◦C overnight
and horseradish peroxidase-coupled anti-species antibodies at room temperature for 1 h. Proteins were
visualized by enhanced chemiluminescence and quantified by densitometry using Fusion solo (Vilber
Lourmat, Baden-Württemberg, Germany). The intensity of immunoblot analysis was quantified by
ImageJ software (National Institutes of Health, Bethesda, MD, USA) [36].
2.9. Statistical Analysis
Statistical analysis was performed using ANOVA (one-way analysis of variance) followed by
Tukey’s multiple comparison test. All the data are expressed as the mean ± SEM (standard error of
the mean). Differences of p < 0.05 were considered significant (GraphPad Prism version 6.0, La Jolla,
CA, USA).
3. Results
3.1. Changes of Chemical Characteristics of Laminaria japonica by Fermentation
Changes by fermentation, including pH, sugar, and reducing sugar contents and total polyphenol
contents of LJEs, are shown in Table 1. Before the fermentation began, the pH of LJ extracts LJE-F1,
LJE-F2, and LJE-F3 was 7.30, 7.31, and 7.34, respectively. After 48 h of fermentation, the pH of LJEs went
down to 4.06, 4.01, and 3.95, respectively. Total sugar and reducing sugar contents were significantly
decreased by the 48-h fermentation in all three types of LJE-Fs. In addition, the total polyphenol
contents in the LJE-Fs were not decreased compared with LJE.
Table 1. Changes of pH, total sugar contents, reducing sugar content, and total polyphenol contents in
LJE-Fs by fermentation.
Measurements Fermentation LJE-F1 LJE-F2 LJE-F3
pH Before 7.30 ± 0.12 1 7.31 ± 0.14 7.34 ± 0.10
After 4.06 ± 0.09 * 4.01 ± 0.11 * 3.95 ± 0.15 *
Total sugar
(mg D-glucose/mL)
Before 4.40 ± 0.13 4.67 ± 0.02 4.93 ± 0.01
After 3.34 ± 0.06 * 4.35 ± 0.07 * 4.04 ± 0.01 *
Reducing sugar
(mg D-glucose/mL)
Before 1.44 ± 0.03 1.39 ± 0.01 1.47 ± 0.03
After 1.39 ± 0.09 * 1.36 ± 0.03 * 1.36 ± 0.03 *
Total polyphenols
(µg gallic acid/mL)
Before 1.14 ± 0.01 1.15 ± 0.07 1.17 ± 0.01
After 0.90 ± 0.01 1.01 ± 0.01 1.11 ± 0.04
1 Values are mean ± SEM of three independent experiments. * Values with an asterisk are significantly different by
t-test (before vs. after fermentation, p < 0.05). Abbreviations: LJE-F1, LJE fermented by LGG; LJE-F2, LJE fermented
by BB-12; and LJE-F3, LJE fermented by a combination of LGG and BB-12.
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3.2. Effect of LJE and LJE-Fs on Cell Viability in Caco-2 Cells
To determine optimal concentrations of LJE and LJE-Fs to treat Caco-2 cells, MTT assay was
performed with various concentrations of LJE and LJE-Fs. The cellular toxicity of all four types of LJE
was evaluated in Caco-2 cells by MTT assay, as shown in Figure 2. Caco-2 cells were treated with 0, 50,
100, 200, and 400 µg/mL of LJE or LJE-Fs for 24 h. There was no significant reduction in cell viability by
different doses of LJE or LJE-Fs. In the case of LJE-F2, cell viability indeed significantly increased at
400 µg/mL compared with the control group (p < 0.05). Based on this cellular toxicity assay as well as
our previous studies in various cell culture models with seaweed extracts [17,37], 100 µg/mL of LJE
or LJE-Fs where there was a minimum alteration (less than 7%) on cell viability compared with the
control was used for the rest of the experiments.
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Figure 2. Effects of LJE and LJE-Fs on Caco-2 cell viability. Caco-2 cells (1 × 105 cells/well) were seeded
in a 24-well plate and treated with LJE or LJE-Fs (0, 50, 100, 200, or 400 µg/mL) for 24 h. Values are
mean ± SEM of four independent experiments (n = 3–6). a p < 0.05 compared with the control by
one-way ANOVA with Tukey’s comparisons test.
3.3. LJE and LJE-Fs Decreased the Production of Nitric Oxide by LPS Stimulus in Caco-2 Cells
To understand how LJE and LJE-Fs act as an anti-inflammatory substance, we investigated the
inhibition of NO production by LJ extracts in LPS-stimulated Caco-2 cell monolayers. The capacity of
LJE and LJE-Fs to attenuate NO production induced by LPS in Caco-2 cells was shown in Figure 3.
Compared with the NO production from the LPS-stimulated group as a control (100%), all four
LJEs significantly decreased NO productions, 44.24% by LJE, 28.73% by LJE-F1, 47.24% by LJE-F2,
and 34.04% by LJE-F3. Thus, LJE and the three types of LJE-Fs appeared to significantly decrease NO
production by LPS stimulus in Caco-2 cells.
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Figure 3. Effects of LJE and LJE-Fs on nitric oxide (NO) production in the lipopolysaccharide
(LPS)-stimulated Caco-2 cells. Caco-2 cell monolayers were incubated for 6 h with 100 µg/mL LJE,
LJE-F1, LJE-F2, or LJE-F3. Then, 1 µg/mL LPS was added, and the cells were incubated for an additional
24 h. Values are mean ± SEM of three independent experiments. Values that do not share the same
superscript are significantly diffe y one-way ANOVA with Tukey’s comparisons test (p < 0.05).
3.4. LJE and LJE-Fs Protected Cac e l Monolayers from Endotoxin Stimulus
Next, we evaluated the preventive effects of LJE and LJE-Fs on intestinal epithelial barrier function
disrupted by LPS stimulus in polarized Caco-2 cell monolayers by measuring TEER (Figure 4). Time
zero (T0)-TEER values were measured before 100 µg/mL LJE or LJE-Fs were added to the upper
compartment of the Caco-2 cell monolayer. Followed by LPS stimulus for 24 h, the TEER values were
evaluated at the end of treatment. Values wer expressed as percentages compared with the control
grou . As result, the LPS-simulated group showed a significant increase in the permeabilization of
Caco-2 monolayers as TEER values were significantly decreased to 62.90% of that of the control (100%).
On the other hand, LJE- and LJE-Fs-treated groups all protected Caco-2 cell monolayers, as indicated
by the significantly increased TEER values (LJE: 85.70%; LJE-F1: 86.76%; LJE-F2: 84.64%; and LJE-F3:
83.58%) compared with the LPS-treated group.
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Figure 4. Effects of LJ and LJE-Fs on permeabilization of Caco-2 cell monolayers measured by
transepithelial electrical resistance (TEER (%). Caco-2 cell monolayers were preincubated with
100 µg/mL LJE, LJE-F1, LJE-F2, or LJE-F3 for 6 h, and the cells were incubated for an additional 24 h
with 1 µg/mL LPS. Caco-2 cell monolayer permeability was evaluated by measuring TEER. The results
are shown as mean ± SEM of three independent experiments. Values that do not share the same
superscript are significantly different by one-way ANOVA with Tukey’s comparisons test (p < 0.05).
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3.5. LJE and LJE-Fs Significantly Attenuate IL-6 Production Induced by LPS Stimulus in Caco-2 Cells
To further evaluate the anti-inflammatory effects of LJE and LJE-Fs, the production of TNF-α and
IL-6 was measured in Caco-2 cell monolayers. LPS stimulation increased both TNF-α (21.90 pg/mL) and
IL-6 (5.47 pg/mL) in Caco-2 cells compared with the no LPS-treated group, which showed no detectable
ranges of TNF-α and IL-6 (Table 2). Only LJE and LJE-F1 significantly decreased the LPS-induced
TNF-α production, whereas LJE-F2 and LJE-F3 did not significantly decrease TNF-α production in
Caco-2 cells. On the other hand, all four extracts, LJE and LJE-Fs, appeared to significantly attenuate
LPS-induced IL-6 production (5.47 pg/mL)—4.16 pg/mL by LJE, 0.92 pg/mL by LJE-F1, 0.91 pg/mL
by LJE-F2, and 0.77 pg/mL by LJE-F3—in Caco-2 cells compared with the LPS-treated group. LJE-Fs
appeared to have superior effects on decreasing IL-6 production compared with LJE itself.
Table 2. Effect of LJE and LJE-Fs on TNF-α and IL-6 production in the LPS-stimulated Caco-2 cells.
Sample TNF-α Levels (pg/mL) IL-6 Levels (pg/mL)
LPS 21.75 ± 0.27 b,1 5.47 ± 0.7 c
LPS+LJE 18.36 ± 1.20 a 4.16 ± 0.26 b
LPS+LJE-F1 18.16 ± 0.01 a 0.92 ± 0.15 a
LPS+LJE-F2 19.82 ± 0.19 b 0.91 ± 0.03 a
LPS+LJE-F3 19.11 ± 0.60 b 0.77 ± 0.05 a
1 Values are mean ± SEM of three independent experiments. Values that do not share the same superscript are
significantly different by one-way ANOVA with Tukey’s comparisons test (p < 0.05). Caco-2 cells were pre-incubated
for 6 h with 100 µg/mL LJE or LJE-Fs and then incubated for 24 h in the absence or presence of LPS (100 µg/mL).
3.6. LJE and LJE-Fs Differentially Promoted Tight Junction (TJ)-Related Protein Expression in Caco-2 Cells
Lastly, two TJ-related proteins, occludin and AMPK, were evaluated to investigate a potential
mechanism of preventive effects of LJE and LJE-Fs on intestinal barrier function. As a result, pretreatment
with all LJE and LJE-Fs attenuated the reduction in protein expression of occludin, a TJ protein that plays
a critical role in regulating permeability of epithelial cells, while LPS reduced the protein expression of
occludin compared with the non-LPS-treated group in Caco-2 cell monolayers (Figure 5). In addition,
LJE, LJE-F1, and LJE-F3 significantly prevented a decrease of phosphorylation of AMPK, a therapeutic
target in intestinal diseases [38] by LPS stimulus in Caco-2 cell monolayers. These results suggest that
LJE and LJE-Fs differentially promoted TJ-related proteins, such as occludin and AMPK that may lead
to enhancing the intestinal epithelial barrier function.
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Figure 5. LJE and LJE-Fs differentially promoted intestinal epithelial barrier function via upregulation
of the tight junction (TJ) in Caco-2 cell monolayers. (A) Representative immunoblot analysis of
occludin, phospho-adenosine monophosphate-activated protein kinase (P-AMPK), total AMPK, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH); (B) intensity of occludin was normalized to
GAPDH, and intensity of P-AMPK was normalized to total AMPK to account for apparent differences
and confirm statistical significance. Caco-2 cells were pre-incubated for 6 h with 100 µg/mL LJE or
LJE-Fs and then incubated for 24 h in the absence or presence of LPS (100 µg/mL). Values are mean ±
SEM of three independent experiments. Values that do not share the same superscript are significantly
different by one-way ANOVA with Tukey’s comparisons test (p < 0.05).
4. Discussion and Conclusions
The major forms of IBDs include Crohn’s disease (CD), ulcerative colitis (UC), and unclassified IBD.
Although causes of IBDs are not fully under tood yet, the asso iation of IBD with an epithe ial barrier
dysfunction haracterized by impaired nutrien s absorp ion, as well as muco al barrier funct ons,
has been appreciated [1,2]. A efective int sti al epi helial TJ barrier is an important pathog nic
fact r to determine gut permeability, because pe etration of luminal noxious molecules vi the
disrupted intestinal TJ induc s a perturbation of the mucosal immune syste and inflammation, which
subs quently act as a trigger for the develo ment of i testinal disease . The roles of extracellular
actors affecting the integrity of intestinal TJ, such as cy okin s, pathogens, and ve food f ctors, ave
been extensively studied [3–5].
Laminaria japonica, a type of brown seaweed, has been studied intensively due to its various
health benefits, su h s anti- xidant, antidiabetic, anti-i flammatory, and anti-obesity properties,
which potentially preve and/or re t lifestyle-rela ed diseases [14,15,17,18,39]. In a few countries
in Asia, LJ is not only a popular dibl seaweed but has al o been an alternative medici e to treat
g strointestinal issues since anc ent times [40]. Based on our previous studies, among the various
brow seaweed that we have screened, LJ appe rs to have the most potent health benefits, including
antidiabetic and anti-infl mmatory ffects in in vitr and in vivo models [17,18]. Recently, fermentation
has be n applied to improve the bioactivity of the seaweed extraction pr cedure [20–23]. However,
the reported effects of fermented LJ extraction are limited to its anti-inflammat ry and anti-oxidant
effects so far [20,21,27,28]. In this study, we investigated the capacity of LJ water extract and h ee types
of ferme t d LJ extracts (LJE-F1, LJE-F2, and LJE-F3) by two n ural r sidents of the gas rointestinal
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tract and probiotic strains, LGG and BB-12, to inhibit the permeabilization of Caco-2 cell monolayers
and their potential mechanism(s).
It has been reported that fermentation not only improves the nutrient contents of food via
the biosynthesis of vitamins, amino acids, and proteins but also promotes the digestibility and
bioavailability of foods [23,24,29,41]. In this study, LJ fermentation by probiotic strains, LGG or BB-12,
or a combination of both resulted in some alterations in total sugar and reduction of sugar levels
in LJE-Fs. Fermentation is a biochemical reaction that metabolizes high-molecular-weight organic
compounds to smaller and simpler molecules. Therefore, it is not surprising that the total sugar and
reducing sugar levels in LJE-Fs were decreased significantly, which may be a sign of fermentation. A
previous report by Eom et al. (2010) also showed a similar result in that LJ extract fermented S. cerevisiae
also caused a significant reduction in total sugar levels compared with LJ extract [27].
In addition, microorganisms during fermentation utilize dietary carbohydrates, especially soluble
dietary fiber, as substrates and produce short-chain fatty acids (SCFAs), primarily acetate, propionate,
and butyrate, as end products [42]. In fact, of the brown seaweeds, LJ contains as much as 80% soluble
dietary fiber, such as alginate, fucans, fucoidans, and laminarins, among its total dietary fiber [43].
Although we did not measure SCFA contents in our LJE and LJE-Fs, it is worth noting that SCFA in
LJE-Fs should be taken into account for its superior effect observed in the present study, such as the
anti-inflammatory effect achieved by further reducing LPS-induced IL-6 production of LJE-Fs in Caco-2
cells. As shown in Figure 2, all three LJE-Fs increased the cell viability of Caco-2 cells, which we were
not able to observe in the LJE-treated cells. Furthermore, the reduction of LPS-induced IL-6 production
by LJE-Fs was significantly higher than that by LJE in Caco-2 cells. It has been reported that SCFAs
indeed play a critical role in the growth of intestinal mucosal cells and Caco-2 cells [42,44], as well as in
the modulation of the inflammatory response in human neutrophils and epithelial cells [45,46].
LJ is also a rich source of polyphenols, which have been considered to be an alternative medicine
to treat IBDs [47,48]. Although the precise mechanism is unclear, polyphenols, such as quercetin,
kaempferol, myricetin, genistein, catechin, and curcumin enhance barrier integrity in intestinal Caco-2
cells [49]. The total polyphenol contents were not significantly altered by fermentation (LJE vs.
LJE-Js) in this study. Unlike our findings, most studies regarding the changes of polyphenol levels in
seaweed by fermentation demonstrated increased polyphenol levels after fermentation. For example,
the fermentation of Eisenia bicyclis, a type of brown seaweed, by yeast strain Candida utilis, enhanced
the levels of phenolic compounds [28], and LJ extract fermented by Aspergillus oryzae appeared to
have more phenolic compounds compared to the LJ extract itself [29]. In addition, the fermentation
of brown seaweed Sargassum siliquanstrum by various lactic acid bacteria, including Lactobacillus sp.,
increased polyphenol levels as well [26]. While it is difficult to compare these results directly, various
factors including type(s) of microorganisms, concentration, and components of substrate depending
on its solvent, duration, and temperature of fermentation, as well as the time of year the seaweed was
harvested, might account for the discrepancy.
The anti-inflammatory and protecting gut integrity effects of LJE and LJE-Fs were comparable in
human epithelial cells based on their capacity to attenuate LPS-induced NO production, as well as
TEER, results in this study (Figures 3 and 4). High levels of NO are involved in the pathophysiological
status of various diseases; its uncontrolled production can impair target tissues during the inflammation
process [50]. LPS-induced NO production was significantly inhibited by pretreatment with LJE and
LJE-Fs in Caco-2 cells, suggesting their capacity to reduce inflammation. In addition, LPS-induced IL-6
levels were also significantly reduced by LJE treatment, and even further reduction was observed in the
groups treated with LJE-Fs in support of the anti-inflammatory effects of LJE and LJE-Fs in Caco-2 cells.
However, LPS-induced TNF-α production was only significantly inhibited by LJE and LJE-F1 but not
by LJE-F2 and F3 in the present study, which may suggest LJE and LJE-Fs differentially regulate TNF-α
production by LPS stimulus. Furthermore, we evaluated functional gut permeability by measuring
TEER, resulting in a protective effect by all four LJ extracts on the permeability of the LPS-induced
Caco-2 cell monolayer. Ko et al. (2014) reported that the administration of LJ water extract (300 mg/kg)
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improved colitis signs, such as colon length, histological score, and IL-1β, IL-6, and TNF-α production
in an in vivo dextran sodium sulfate-induced colitis model [39]. In fact, patients with IBDs appeared
to have significantly increased TNF-α and IL-6 levels [49]; therefore, blocking and/or reducing TNF-α
and IL-6 signaling has been proposed to be an effective treatment for IBDs. Therefore, our finding
of LJE and LJE-Fs’s capacity to reduce LPS-induced NO and IL-6 in Caco-2 cells could support their
potential beneficial effects on gut health, including their potential as an alternative treatment for IBs,
although further study is warranted to dissect the different responses to TNF-α reduction among LJ
extracts in the present study.
Furthermore, bioactive compounds of LJ water extracts, such as fucoidans, could in part explain
the anti-inflammatory and gut barrier protective effects of LJ extracts in Caco-2 cell monolayers
observed in the present study. Fucoidan extracted from LJ is a combination of various polysaccharides,
mainly made of fucose, galactose, and sulfate, with smaller amounts of mannoses, glucuronic acid,
glucose, rhamnose, arabinose, and xylose [51]. In detail, Hwang et al. (2016) demonstrated that
low-molecular-weight fucoidan, the sulfated polysaccharides extracted from Sargassum hemiphyllum
(100 µg/mL), significantly decreased the inflammation of the intestinal barrier by inhibiting IL-1β
and TNF-α and promoting IL-10 and IFNγ in Caco-2 cells [52]. Iraha et al. (2013) demonstrated
that fucoidan isolated from Cladosiphone okamuranus Tokida protected gut integrity via regulation of
claudin-1 in H2O2-stimulated Caco-2 cells [11]. Thus, both a crude water extract of LJ and LJ-derived
fucoidans reduced inflammation and protected the intestinal barrier.
Occludin is an integral membrane protein that is specifically located at the TJs in the epithelia [49].
Although the function of occludin is unclear, a few studies using in vivo and in vitro models
demonstrated the important roles of occludin in the TJ structure and permeability in the intestinal
epithelia [49,53]. Unlike claudins, which mainly affect the flux of smaller-sized molecules and ions
through a fixed pore, occludin plays an important role in the flux of large macromolecules, such as
inulin and dextran, in the paracellular barrier [53]. LJE and LJE-Fs were able to block the inhibition
of the protein expression of occludin by LPS stimulus in Caco-2 cells in the present study (Figure 5).
Presumably, the anti-inflammatory effect of LJE and LJE-Fs is partially due to the enhancement of
occludin expression, which is crucial to the selective flux of macromolecules, including bacterial
antigens. Lastly, cumulative evidence supports the notion that a well-known energy sensor, AMPK,
indeed has beneficial effects on gut health by increasing nutrient absorption, decreasing intestinal
inflammation, and improving gut barrier function [38]. Among the four LJ extracts, pretreatment
with LJE, LJE-F1, and LJE-F3 significantly attenuated the reduction in phosphorylation of AMPK in
the LPS-stimulated Caco-2 cell monolayer. In summary, all four LJ extracts significantly prevented
the reduction in the protein expression of occludin, whereas LJ, LJE-F1, and LJE-F3 attenuated the
inhibition of the phosphorylation of AMPK compared with the LPS-treated group in Caco-2 cells,
suggesting that the gut-integrity-protective effects of LJE and LJE-Fs are partially regulated by occludin
and AMPK activation.
In conclusion, LJ water extract and three types of fermented LJ extracts by probiotic strains LGG,
BB-12, or a combination of both, appeared to have potential gut-health-promoting effects by reducing
intestinal inflammation and promoting the gut barrier function by partially regulating the tight
junction-related proteins occludin and AMPK in human intestinal epithelial cells. A major limitation
of our study is that the regulation of intestinal barrier function cannot be elucidated using an in vitro
model alone due to the complexity of the intestinal barrier. In addition, further study is warranted to
clarify the more precise mechanism(s) of LJEs by evaluating a diverse range of inflammatory cytokines,
as well as more TJ-related proteins. Nevertheless, we believe that our findings support the potential
benefit of LJE and LJE-Fs as an appropriate therapeutic agent for the treatment of inflammatory
bowel diseases.
Nutrients 2019, 11, 1001 12 of 14
Author Contributions: H.-S.Y. researched the data and wrote the original draft. F.G.H. and M.L. contributed
to data interpretation and scientific discussion. I.K. and G.Z. interpreted the data and edited the manuscript.
Y.L. participated in the design of the study, data interpretation, and manuscript writing. All authors read and
approved the final manuscript.
Funding: This research was funded by the National Research Foundation of Korea, grant numbers
NRF-2013R1A1A1057573 and NRF-2017R1D1A3B03031665.
Acknowledgments: This study forms a part of Hyo-Seon Yang’s master’s thesis (2016) at Jeju National University
and has been modified with new data to submit to Nutrients. Lastly, we would like to thank the research and
development center at Maeil Dairy Co. (Pyeongtaek, South Korea) for the kind gift of probiotics LGG and BB-12.
Conflicts of Interest: The authors declare no conflicts of interest.
Abbreviations
AMPK adenosine monophosphate (AMP)-activated protein kinase
BB-12 Bifidobacterium animalis ssp. lactis BB-12
IBD inflammatory bowel diseases
LGG Lactobacillus rhamnosus LGG
LJ Laminaria japonica
LJE Laminaria japonica extract
LJE-Fs Fermented Laminaria japonica extract
LPS lipopolysaccharides
NO nitric oxide
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TJ tight junction
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